Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 9, 2019 (7 years ago)

Superior Pain & Itch Relief

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Superior Pain & Itch Relief (lidocaine) Cream, 4%, packaged in a) 1 OZ (NDC 69804-070-05), b) 2 OZ (NDC 69804-070-02), and c) 4 OZ (NDC 69804-070-03) jars, OTC, Manufactured, packed & distributed by Pain Relief Naturally, Salem, OR 97301.

Affected NDCs 69804-0070-02 69804-0070-03 69804-0070-05

Compare with the code on your package — it is the most precise check available.

Drug: Lidocaine

Recalling firm
Ridge Properties, LLC
NDC code
69804-070-05
Origin
OR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1858-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Lidocaine recalls

See all
Class II · Moderate risk

Lidocaine Ointment USP

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Ongoing Wrong potency / content Sun Pharma /Taro D-0848-2026
Class III · Low risk

Lidolog Kit

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Ongoing Labeling / mix-up Asclemed USA Inc. D-0713-2026

Other recalls by Ridge Properties, LLC

All 2019 recalls
Class II · Moderate risk

Soothing Sore Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-077-14 D-1861-2019
Class II · Moderate risk

Soothing Sore Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-074-05 D-1860-2019
Class II · Moderate risk

Superior Pain & Itch Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-073-14 D-1859-2019
Class II · Moderate risk

PRE-TAT (lidocaine)

Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Terminated Microbial contamination Ridge Properties, LLC NDC 69804-019-14 D-1857-2019